NCT01752543View on ClinicalTrials.gov

Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Heart Failure
Interventions
DRUG

Conivaptan

Conivaptan treatment: 20 mg bolus followed by infusion of 2 mg/hour

DRUG

Placebo (Dextrose)

Placebo treatment: 20 mg bolus followed by infusion of 2 mg/hour

Trial Locations (1)

2100

Department of Cardiology, Copenhagen University Hospital, Rigshospital, Copenhagen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

Finn Gustafsson

OTHER

NCT01752543 - Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure Patients | Biotech Hunter | Biotech Hunter